Literature DB >> 18061597

EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma.

Ferga C Gleeson1, Elizabeth Rajan, Michael J Levy, Jonathan E Clain, Mark D Topazian, Gavin C Harewood, Georgios I Papachristou, Naoki Takahashi, Charles B Rosen, Gregory J Gores.   

Abstract

BACKGROUND: The clinical impact of EUS-guided FNA (EUS-FNA) in regional lymph-node staging in patients with unresectable hilar cholangiocarcinoma before liver transplantation has yet to be determined.
OBJECTIVES: To determine the frequency of regional lymph-node detection, identify EUS features predictive of benign or malignant lymph nodes, compare EUS lymph-node detection rates to CT/magnetic resonance imaging and exploratory laparotomy, and evaluate the impact of EUS-FNA on patient selection for liver transplantation.
DESIGN: Retrospective case series.
SETTING: Tertiary referral EUS unit. PATIENTS: Clinical, radiographic, EUS, cytologic, and surgical data of 47 patients with unresectable hilar cholangiocarcinoma before liver transplantation were evaluated.
INTERVENTIONS: EUS-FNA. MAIN OUTCOME MEASUREMENTS: Lymph-node morphology and echo features.
RESULTS: EUS identified lymph nodes in all patients. FNA of 70 lymph nodes identified metastases in 9 nodes of 8 patients (17%), who were then precluded from transplantation before a staging laparotomy. Identified lymph nodes, irrespective of malignant involvement, were typically oval and geographic in shape, of mixed echogenicity, with a hypoechoic border. There were no morphologic criteria or echo features to correlate with nodal malignancy. The EUS finding of absent regional lymph-node metastases was confirmed in 20 of 22 by a subsequent exploratory staging laparotomy. LIMITATIONS: Single institution, retrospective analysis.
CONCLUSIONS: EUS identified lymph nodes in all patients, and confirmation of malignant lymph nodes detected by FNA precluded 17% of patients from transplantation. EUS-FNA of visualized lymph nodes irrespective of appearance is advised because morphology and echo features do not predict malignant involvement.

Entities:  

Mesh:

Year:  2007        PMID: 18061597     DOI: 10.1016/j.gie.2007.07.018

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  40 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

2.  Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter?

Authors:  Anthony T Ruys; Fiebo J W Ten Kate; Olivier R Busch; Marc R Engelbrecht; Dirk J Gouma; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2011-09-26       Impact factor: 3.647

Review 3.  Usefulness of endoscopic ultrasonography in hepatology.

Authors:  Julien Bissonnette; Sarto Paquin; Anand Sahai; Gilles Pomier-Layrargues
Journal:  Can J Gastroenterol       Date:  2011-11       Impact factor: 3.522

Review 4.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 5.  Role of endoscopy in primary sclerosing cholangitis.

Authors:  Nabeel S Koro; Samer Alkaade
Journal:  Curr Gastroenterol Rep       Date:  2013-12

6.  Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma.

Authors:  Jaap Jacob Kloek; Otto Marinus van Delden; Deha Erdogan; Fibo Jan ten Kate; Erik Anthoni Rauws; Olivier-Robert Busch; Dirk Joan Gouma; Thomas Mathijs van Gulik
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

7.  Larger short-axis length of lymph nodes: another predictor for malignant involvement.

Authors:  Mitsunobu Matsushita; Kazushige Uchida; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

8.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

9.  Quality indicators for EUS.

Authors:  Sachin Wani; Michael B Wallace; Jonathan Cohen; Irving M Pike; Douglas G Adler; Michael L Kochman; John G Lieb; Walter G Park; Maged K Rizk; Mandeep S Sawhney; Nicholas J Shaheen; Jeffrey L Tokar
Journal:  Am J Gastroenterol       Date:  2014-12-02       Impact factor: 10.864

Review 10.  Usefulness of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of hepatic, gallbladder and biliary tract Lesions.

Authors:  Ghassan M Hammoud; Ashraf Almashhrawi; Jamal A Ibdah
Journal:  World J Gastrointest Oncol       Date:  2014-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.